Package Leaflet: Information for the User
Analgilasa 500 mg/ 30 mg/ 10 mg film-coated tablets
paracetamol/ caffeine / codeine phosphate hemihydrate
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.Keep this leaflet, you may need to read it again.
Contents of the pack
Analgilasa is an association of paracetamol, codeine, and caffeine. Paracetamol is a pain-relieving medication whose effects are enhanced by the action of codeine and caffeine.
This medication is indicated for the symptomatic treatment of mild or moderate pain.
Codeine belongs to a group of medications called opioid analgesics that act by relieving pain. It can be used alone or in combination with other analgesics such as paracetamol.
You should consult a doctor if your pain worsens or does not improve after 3 days.
Do not take Analgilasa
Warnings and precautions
Consult your doctor or pharmacist before starting to take Analgilasa
During treatment with Analgilasa, immediately inform your doctor if you have serious diseases, such as severe renal insufficiency or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling unwell (nausea) and vomiting.
In chronic alcoholics, caution should be taken not to take more than 2 g/day of paracetamol.
Codeine is transformed into morphine in the liver by an enzyme. Morphine is the substance that produces pain relief. Some people have a variation of this enzyme that can affect people in different ways. In some people, morphine is not produced or is produced in very low quantities, and it will not provide sufficient pain relief. Other people are more likely to suffer from serious adverse reactions because they produce a very high amount of morphine. If you experience any of the following side effects, you should stop taking this medication and seek medical help immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, nausea or vomiting, constipation, loss of appetite.
Do not take more than the recommended dose. To do this, avoid taking other medications that contain paracetamol or codeine at the same time.
The prolonged or frequent use of analgesics to treat headaches can worsen the symptoms, which should not be treated with higher doses of the medication.
With repeated administration of this medication, physical dependence and tolerance (the body gets used to it and more medication is needed to achieve the same effect) may appear. The administration should be gradually suspended after prolonged treatments.
The benefit/risk balance during continued use should be periodically reevaluated by the doctor.
If the pain or fever persists for more than 3 days, or the pain or fever worsens or other symptoms appear, the treatment should be discontinued and the doctor consulted.
Children and adolescents
Use in children and adolescents after surgery
Codeine should not be used to relieve pain in children and adolescents after tonsillectomy or adenoidectomy due to obstructive sleep apnea syndrome.
Use in children with respiratory problems
Codeine is not recommended for use in children with respiratory problems since the symptoms of morphine toxicity can be worse in these children.
Other medications and Analgilasa
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medications, including those bought without a prescription.
Paracetamolmay interact with the following medications:
Tell your doctor or pharmacist if you are taking flucloxacillin (an antibiotic), due to a serious risk of alteration of blood and fluids (called metabolic acidosis) that requires urgent treatment (see section 2).
Do not use with other analgesics (pain-relieving medications) without consulting your doctor.
As a general rule for any medication, it is recommended to systematically inform your doctor or pharmacist if you are being treated with another medication. In the case of treatment with oral anticoagulants, it can be administered occasionally as the analgesic of choice.
On the other hand, codeinemay interact with the following medications:
Similarly, caffeinemay interact with the following medications:
Interference with analytical tests: if you are going to undergo any diagnostic test (including blood or urine tests), inform your doctor that you are taking this medication, as it may alter the results.
Taking Analgilasa with alcohol
You should not consume alcohol during treatment with Analgilasa due to the increased risk of adverse reactions due to codeine. The use of paracetamol in patients who habitually consume alcohol (three or more alcoholic beverages a day: beer, wine, liquor...) can cause liver damage.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
Taking medications during pregnancy can be dangerous for the embryo or fetus and should be monitored by your doctor.
Analgilasa can be used during pregnancy if necessary. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time.
Contact your doctor if the pain or fever does not decrease or if you need to take the medication more frequently.
Breastfeeding
Ask your doctor or pharmacist for advice before taking any medication.
Small amounts of paracetamol may appear in breast milk.
Do not take codeine if you are breastfeeding. Codeine and morphine pass into breast milk.
Driving and using machines
This medication may alter your ability to drive vehicles or operate machines that require special attention.
Therefore, do not drive or operate machines until you have checked how you tolerate this medication.
Alcohol can potentiate this effect, so you should not drink alcoholic beverages during treatment.
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The duration of treatment will be determined by your doctor. Do not take this medication for longer than indicated by your doctor.
If the pain and/or fever persist for more than 3 days or the pain or fever worsen or other symptoms appear, you should discontinue treatment and consult your doctor. This medication should not be taken for more than 3 days.
The recommended dose is:
Use in children and adolescents
It is necessary to respect the defined posologies according to weight. The age of the adolescent is given for informational purposes.
This medication should not be administered to adolescents with less than 33 kg of body weight.
Children under 12 years should not take Analgilasa due to the risk of serious respiratory problems.
Patients with kidney or liver disease
The dose should be reduced and the interval between intakes increased. They should consult their doctor.
Elderly patients
They should consult their doctor.
This medication is taken orally. The ingestion of the tablets can be helped with a sip of water or another non-alcoholic liquid.
If you think the action of Analgilasa is too strong or too weak, tell your doctor or pharmacist.
If you take more Analgilasa than you should
If you have taken more Analgilasa than you should or have accidentally ingested the contents of the package, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 915 620 420, indicating the medication and the amount ingested.
If you have taken an overdose, you should go to a medical center immediately, even if you do not have symptoms, since they often do not appear until 3 days after taking the overdose, even in cases of severe poisoning.
The symptoms of overdose due to paracetamolcan be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), abdominal pain.
The symptoms of overdose due to codeinecan be: initial excitement, anxiety, insomnia, and later in certain cases drowsiness, headache, changes in blood pressure, arrhythmias, dry mouth, skin rashes, tachycardia, convulsions, gastrointestinal disorders, nausea, vomiting, and respiratory depression.
The symptoms of overdose due to caffeinecan be: difficulty urinating, insomnia, restlessness (nervous overexcitement).
Treatment of the overdose is more effective if started within 4 hours after taking the medication.
Patients treated with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
If you forget to take Analgilasa
Do not take a double dose to make up for forgotten doses. Take the missed dose as soon as you remember and if your next dose is near in time, skip the missed dose and continue taking the medication as scheduled. In case of doubt, consult your doctor or pharmacist.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Analgilasa can cause adverse effects, although not all people suffer from them.
The observed adverse effects are described below according to their frequency of presentation: very frequent(may affect more than 1 in 10 patients), frequent(may affect up to 1 in 10 patients), infrequent(may affect up to 1 in 100 patients), rare(may affect up to 1 in 1,000 patients), very rare(may affect up to 1 in 10,000 patients), and of unknown frequency(cannot be estimated from the available data).
The following adverse effects have been observed with paracetamol:
General
Rare:discomfort.
Very rare:allergic reactions (hypersensitivity) ranging from a simple skin rash (redness or inflammation of the skin) or urticaria (hives) to anaphylactic shock (a type of severe allergic reaction).
Gastrointestinal
Rare:increased liver transaminases (liver enzymes).
Very rare:hepatotoxicity (liver toxicity) and jaundice (yellowing of the skin and mucous membranes).
Unknown frequency:acute pancreatitis in patients with a history of cholecystectomy.
Metabolism
Very rare:hypoglycemia (reduced glucose levels in the blood).
Unknown frequency:a severe condition that can make the blood more acidic (called metabolic acidosis) in patients with severe illness using paracetamol (see section 2).
Blood
Very rare:thrombocytopenia (reduced platelets in the blood), agranulocytosis, leukopenia, neutropenia (decreased white blood cells in the blood), hemolytic anemia (decreased red blood cells in the blood).
Vascular Disorders
Rare:hypotension (decreased blood pressure).
Kidney and Urinary
Very rare:sterile pyuria (cloudy urine), adverse renal effects.
Skin and Subcutaneous Tissue
Very rare cases of severe skin reactions have been reported.
The following adverse effects have been described with codeine, whose frequency has not been established with precision:
General
Discomfort, drowsiness (somnolence), skin rashes.
Gastrointestinal
Constipation, nausea, and yellowing of the skin and eyes (jaundice).
Metabolism
Decreased blood glucose (hypoglycemia).
Blood
Blood disorders.
The following adverse effects have been observed with caffeine, whose frequency has not been established with precision:
Nervous System
Nervousness, restlessness.
Gastrointestinal
Irritation of the stomach or intestine.
Cardiac
Tachycardias.
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use Analgilasa after the expiration date that appears on the packaging after CAD.
The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need at the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Analgilasa 500 mg/30 mg/10 mg tablets
Appearance of the Product and Content of the Packaging
Each package contains 20 tablets. The medicine is presented in a blister pack (aluminum/PVC) that individualizes and protects each pharmaceutical form.
Marketing Authorization Holder
Faes Farma, S.A.
Autonomia Etorbidea, 10
48940 Leioa (Bizkaia)
Spain
Manufacturer
Faes Farma, S.A.
Maximo Agirre Kalea, 14
48940 Leioa (Bizkaia)
Spain
Or
Faes Farma, S.A.
Parque Científico y Tecnológico de Bizkaia
Ibaizabal Bidea, Edificio 901
48160 Derio (Bizkaia)
Spain
Date of the Last Revision of this Prospectus:January 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es